Skip to main content
BioAdvance NewsNuPathePortfolio News

FDA Accepts NuPathe Inc. (PATH)’s Migraine Patch NDA Resubmission for Filing

By August 6, 2012November 1st, 2024No Comments

FDA Accepts NuPathe Inc. (PATH)’s Migraine Patch NDA Resubmission for Filing
Read more here